2024-11-06 - Analysis Report
## Eli Lilly and Co. (LLY) Stock Analysis Report 

**1. Performance vs. S&P 500**

Eli Lilly and Co. (LLY) is a pharmaceutical company that develops and manufactures medicines for various conditions. 

* **Cumulative Return:** LLY: 761.23%, VOO (S&P 500): 134.06%
* **Relative Outperformance:** LLY has significantly outperformed the S&P 500, with a cumulative return difference of 627.17%. This places LLY in the 78.3rd percentile of historical outperformance relative to the S&P 500. 

**Alpha and Beta Analysis:**

| Year | CAGR | MDD | Alpha | Beta |
|------|------|----------|-----|-------|
| 2015-2017 | 20.6% | 19.6% | -9.6% | 0.8 |
| 2016-2018 | 39.6% | 19.2% | 14.9% | 0.7 |
| 2017-2019 | 76.2% | 17.2% | 33.1% | 0.7 |
| 2018-2020 | 99.4% | 22.1% | 60.3% | 0.7 |
| 2019-2021 | 140.4% | 22.1% | 50.6% | 0.7 |
| 2020-2022 | 176.7% | 22.1% | 159.0% | 0.7 |
| 2021-2023 | 252.2% | 18.6% | 223.4% | 0.5 |
| 2022-2024 | 196.6% | 18.7% | 176.0% | 0.6 |

The analysis shows that LLY has consistently outperformed the market (Alpha > 0) with a relatively low beta (0.5-0.8), indicating less volatility than the broader market. 

**2. Recent Price Movement**

* **Closing Price:** 806.06
* **5-day Moving Average:** 821.54
* **20-day Moving Average:** 888.31
* **60-day Moving Average:** 910.4

LLY's price is currently below all three moving averages, suggesting a potential downward trend in the short term. 

**3. Technical Indicators**

* **RSI:** 11.69 (Oversold) - This indicates that the stock is currently oversold, potentially signaling a rebound. 
* **PPO:** -1.31 (Bearish) - This suggests that the stock is in a bearish momentum.
* **Delta_Previous_Relative_Divergence:** -14.38 (Negative) - This indicates a short-term downward trend.
* **Expected Return:** 97.94% - This represents the potential long-term (2+ years) outperformance compared to the S&P 500, assuming a continued strong performance.

**4. Recent Earnings and Outlook**

| Date | EPS | Revenue |
|---|---|---|
| 2024-10-30 | 1.08 | 11.44 B$ |
| 2024-08-08 | 3.29 | 11.30 B$ |
| 2024-04-30 | 2.49 | 8.77 B$ |
| 2023-11-02 | -0.06 | 9.50 B$ |
| 2024-10-30 | -0.06 | 9.50 B$ |

LLY's recent earnings have been strong, exceeding expectations for the quarter ending October 2024. The company has shown consistent revenue growth and profitability, demonstrating a strong financial position. 

**5. Financial Information**

**1) Revenue and Profitability:**

| Quarter | Revenue | Profit Margin |
|---|---|---|
| 2024-09-30 | $11.44B | 81.02% |
| 2024-06-30 | $11.30B | 80.80% |
| 2024-03-31 | $8.77B | 80.91% |
| 2023-12-31 | $9.35B | 80.88% |
| 2023-09-30 | $9.50B | 80.42% |

LLY demonstrates consistent revenue growth and high profitability margins, highlighting its strong financial performance.

**2) Capital and Profitability:**

| Quarter | Equity | ROE |
|---|---|---|
| 2024-09-30 | $14.24B | 6.81% |
| 2024-06-30 | $13.56B | 21.88% |
| 2024-03-31 | $12.81B | 17.51% |
| 2023-12-31 | $10.77B | 20.33% |
| 2023-09-30 | $11.22B | -0.51% |

The company's ROE fluctuates but remains generally strong, indicating its ability to generate profits from shareholder equity. 

**6. News and Recent Issues**

* **Recent Earnings Release:** [Insert Link to News Release] - Highlight key takeaways from the latest earnings report, focusing on revenue, EPS, and guidance. 
* **Recent Market Outlook:** [Insert Link to Market Analyst Articles or Reports] - Summarize analyst opinions on LLY's stock performance, including potential catalysts, risks, and price targets.
* **Analyst Opinions and Performance Highlights:** [Insert Link to Analyst Ratings or FINBOLD Reports] - Include information on buy/sell recommendations, price targets, and recent analyst commentary on LLY.

**7. Comprehensive Analysis**

Overall, LLY is a strong performer with a history of outperforming the market and a solid financial position.  While recent technical indicators suggest short-term weakness, the company's fundamental strengths and strong earnings suggest long-term growth potential. However, it is important to consider the current market conditions and consult with a financial advisor before making any investment decisions. 
